SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-031778
Filing Date
2024-06-28
Accepted
2024-06-28 16:34:35
Documents
14
Period of Report
2024-06-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20031848_8k.htm   iXBRL 8-K 31638
2 EXHIBIT 3.1 ef20031848_ex3-1.htm EX-3.1 206740
  Complete submission text file 0001140361-24-031778.txt   413257

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adma-20240627.xsd EX-101.SCH 3880
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20240627_lab.xml EX-101.LAB 22691
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20240627_pre.xml EX-101.PRE 16562
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20031848_8k_htm.xml XML 4191
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 241086262
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)